HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.020
+0.020 (1.00%)
At close: Aug 7, 2026, 4:00 PM EDT
1.996
-0.024 (-1.17%)
After-hours: Aug 7, 2026, 7:15 PM EDT

HeartSciences Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Revenue
0000.020.010.01
Revenue Growth
-0.71%-0.71%-76.61%261.17%-64.17%-43.86%
Gross Profit
0000.0100.01
Operating Income
-8.41-8.41-8.35-6.31-6.11-4.71
Net Income
-9.14-9.14-8.77-6.61-6.35-4.83
Earnings Per Share
-3.48-3.48-9.34-18.74-5.26-145.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Cash & Investments
1.661.661.15.811.660.92
Total Debt
3.943.942.991.041.576.16
Net Cash (Debt)
-2.28-2.28-1.894.770.09-5.24
Net Cash Growth
---4943.83%--
Net Cash Per Share
-0.87-0.87-2.0113.532.85-158.02

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Operating Cash Flow
-7.43-7.43-7.41-6.07-5.77-3.64
Capital Expenditures
-0-0-0-0.06-0.02-0
Free Cash Flow
-7.43-7.43-7.42-6.13-5.79-3.65
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Gross Margin
59.06%59.06%56.78%67.31%45.71%45.11%
Operating Margin
-194787.00%-194787.00%-192013.00%-33902.00%-118698.00%-32765.60%
Pretax Margin
-211666.47%-211666.47%-201499.52%-35511.87%-123384.27%-33592.57%
Profit Margin
-211666.00%-211666.00%-201500.00%-35511.90%-123384.00%-33592.60%
FCF Margin
-172037.00%-172037.00%-170486.00%-32981.90%-112464.00%-25367.50%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
PS Ratio
1823.801439.53903.00336.121743.70-